Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs

We examined the added therapeutic benefit of the most expensive drugs prescribed to Medicare Part D beneficiaries in the United States.

Source: Value in Health - January 5, 2021 Category: International Medicine & Public Health Authors: Michael J. DiStefano, So-Yeon Kang, Farah Yehia, Christian Morales, Gerard F. Anderson Source Type: research